• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome
CONCLUSIONS: ARC-HBR score was independently associated with an increased risk of MACE in patients with ACS after an emergent PCI. Moreover, it had a similar diagnostic ability for predicting MACE within two years compared to the CADILLAC risk score.PMID:36682715 | DOI:10.1016/j.jjcc.2023.01.003
Source: Journal of Cardiology - January 22, 2023 Category: Cardiology Authors: Hirokazu Shimono Akihiro Tokushige Daisuke Kanda Ayaka Ohno Masao Hayashi Mana Fukuyado Mitsumasa Akao Mariko Kawasoe Ryo Arikawa Hideaki Otsuji Hideto Chaen Hideki Okui Naoya Oketani Mitsuru Ohishi Source Type: research

Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis
ConclusionsRoutine GPI administration in STEMI resulted in a reduction in mortality, driven by reductions in recurrent ischemic events—however predominantly in pre-prasugrel/ticagrelor trials. Trials with contemporary STEMI management are needed to confirm these findings.RésuméContexteLes lignes directrices recommandent le traitement d’appoint par des inhibiteurs des glycoprotéines IIb-IIIa (IGP) uniquement chez certains patients ayant subi un infarctus du myocarde avec élévation du segment ST (STEMI) aigu. Cette étude visait à évaluer l’utilisation systématique des IGP chez les patients ayant subi un STEMI ...
Source: Canadian Journal of Cardiology - November 2, 2019 Category: Cardiology Source Type: research

Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention.
CONCLUSIONS: IC versus IV abciximab did not enhance myocardial reperfusion in non-selected patients with STEMI undergoing primary PCI after aspiration thrombectomy had successfully been performed. PMID: 30460974 [PubMed - as supplied by publisher]
Source: Cardiovascular Journal of Africa - November 20, 2018 Category: Cardiology Authors: Bedjaoui A, Allal K, Lounes MS, Belhadi CE, Mekarnia A, Sediki S, Kara M, Azaza A, Monsuez JJ, Benkhedda S Tags: Cardiovasc J Afr Source Type: research

Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction.
CONCLUSIONS: The KorMI system would be a useful tool for predicting outcomes in survivors treated with guideline-adherent optimal therapies after AMI. PMID: 29856143 [PubMed]
Source: Korean Circulation Journal - June 3, 2018 Category: Cardiology Tags: Korean Circ J Source Type: research

Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program Original Articles
Conclusions— In this national cohort, 18% of patients undergoing PCI had contraindications to common antiplatelet medications. Approximately 6% of those patients received a contraindicated medication with attendant bleeding risk, although this did not translate into significantly higher risk of 30-day mortality. Continued efforts to reduce contraindicated medication use may help avoid periprocedural complications.
Source: Circulation: Cardiovascular Quality and Outcomes - July 18, 2016 Category: Cardiology Authors: Barnes, G. D., Stanislawski, M. A., Liu, W., Baron, A. E., Armstrong, E. J., Ho, P. M., Klein, A., Maddox, T. M., Nallamothu, B. K., Rumsfeld, J. S., Tsai, T. T., Bradley, S. M. Tags: Platelets, Anticoagulants, Percutaneous Coronary Intervention, Stent, Quality and Outcomes Original Articles Source Type: research